Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT06730555

Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

Led by University of Miami · Updated on 2026-02-03

40

Participants Needed

1

Research Sites

161 weeks

Total Duration

On this page

Sponsors

U

University of Miami

Lead Sponsor

N

National Institute on Drug Abuse (NIDA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).

CONDITIONS

Official Title

Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Syringe services programs must operate in jurisdictions vulnerable to HIV as identified by the CDC or Ending the HIV Epidemic initiative
  • Serve at least 300 unique participants each year
  • Not currently offer routine opt-out HIV and Hepatitis C testing
  • Be able and willing to collect aggregated data on participants offered testing, those tested, and those linked to care, including participant demographics
  • Have key staff consent to participate in surveys, interviews, and practice facilitation throughout the study
Not Eligible

You will not qualify if you...

  • Syringe services programs currently receiving or that have previously received Frontline Communities in the United States (FOCUS) funding
  • Syringe services programs that have already implemented routine opt-out HIV/HCV testing
  • Syringe services programs currently participating in the SAIA-SSP-HIV study (NCT06025435)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Miami

Miami, Florida, United States, 33136

Actively Recruiting

Loading map...

Research Team

H

Hansel Tookes, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SCREENING

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here